Blog

GTL Hospital Indemnity Plans: A Smart Supplemental Solution for Agents

GTL hospital indemnity plans offer agents a practical way to help clients manage rising out-of-pocket healthcare costs while expanding their own product portfolio. Designed to pay cash benefits directly to the policyholder, these plans work alongside major medical coverage. This means; Medicare Advantage, or Medicare Supplement plans.

What Is a Hospital Indemnity Plan

A hospital indemnity plan provides a fixed cash benefit for covered events such as hospital admissions, daily confinement, ICU stays, and certain outpatient services. GTL’s hospital indemnity plans are known for simple plan designs, guaranteed renewable coverage, and predictable benefits. Because clients recieve payments directly, they can use funds for co-pays, deductibles or everyday expenses.

Why Agents Should Offer GTL Hospital Indemnity Plans

For agents, hospital indemnity plans are easy to explain and easy to position. As Medicare Advantage plans continue to shift cost-sharing to beneficiaries, clients are increasingly exposed to unexpected hospital expenses. Hospital indemnity coverage helps fill these gaps without replacing existing insurance.

Key agent-friendly advantages include:

• Straightforward underwriting with limited health questions
• Affordable premiums that appeal to budget-conscious clients
• Flexible use of benefits, increasing perceived value
• Year-round sales opportunities, not limited to AEP or OEP

If you are ready to join our team; click here for online contracting

These features make GTL plans ideal for cross-selling to Medicare beneficiaries, individuals with high-deductible health plans, and clients concerned about hospitalization costs.

Ideal Clients for Hospital Indemnity Coverage

GTL hospital indemnity plans are especially effective for Medicare Advantage enrollees facing daily hospital copays, retirees on fixed incomes, and working individuals seeking extra financial protection. Agents can position the plan as a financial safety net rather than traditional insurance, which resonates strongly with today’s consumers.

Watch a YouTube video – Why agents should include ancillary products with MA sales

Final Thoughts

Adding GTL hospital indemnity plans to your product lineup allows you to address a real client need while generating consistent commissions. With simple benefits, broad appeal, and strong supplemental value, these plans can strengthen client relationships and help agents stand out in a competitive market.

Stay up-to-date on the latest webinars an agent events.

Medicare Supplement Costs and Coverage: What Beneficiaries Need to Know

If you’re exploring ways to reduce out-of-pocket medical expenses, a Medicare Supplement Insurance plan (Medigap) can help fill the gaps left by Original Medicare. These standardized plans are designed to make healthcare costs more predictable, offering peace of mind and broader financial protection. We will go over the Medicare supplement costs and coverage and help you decide if this is right for you.

What Medicare Supplement Plans Cover

Medigap plans labeled A, B, D, G, K, L, M, and N offer the same benefits no matter which insurance company sells them. While the level of coverage varies by plan letter, most include:

• Part A coinsurance and hospital costs
• Part B coinsurance or copayments
• Blood (first 3 pints)
• Hospice care coinsurance
• Skilled nursing facility coinsurance (many plans)
• Part A deductible
• Foreign travel emergency benefits (select plans)

Today’s most popular option, Plan G, offers broad protection by covering nearly all Medicare-approved costs except the Part B deductible.

What Medigap Does Not Cover

It’s important to understand what Medicare Supplement plans exclude. Medigap policies do not cover:

• Prescription drugs (Part D is required separately)
• Routine dental, vision, and hearing care
• Long-term care or custodial care
• Services not approved by Medicare

Beneficiaries often pair Medigap with standalone dental, vision, and hearing plans for more complete coverage.

Watch a YouTube video on Medicare Advantage vs. Medicare Supplement

How Much Medicare Supplement Plans Cost

Medigap premiums vary widely. The main factors that influence cost include:

Plan Type

Plans with more benefits typically cost more. Plans with cost-sharing features often come with lower premiums.

Age and Rating Method

Carriers price Medigap plans using:

• Community-rated premiums
• Issue-age-rated premiums
• Attained-age-rated premiums

The rating method affects how your premium changes over time.

Location

Medigap costs vary by state and even by ZIP code due to regional healthcare expenses.

Tobacco Use and Enrollment Timing

Carriers may charge higher rates for tobacco users or applicants enrolling outside their guaranteed-issue period.

Available Discounts

Household or multi-enrollee discounts may lower monthly premiums.

Agents; are you ready to join the Crowe team – click here for online contract

Why Many Beneficiaries Choose Medigap

Medicare Supplement plans are favored for their predictable costs, nationwide provider access, and minimal out-of-pocket expenses. With no networks or referrals required, Medigap offers flexibility that many retirees value.

A Medicare Supplement plan can significantly reduce healthcare costs and eliminate many gaps in Original Medicare. Reviewing coverage options, comparing premiums, and pairing your plan with Part D ensures you get comprehensive protection tailored to your needs.

Stay up-to-date on agent events and information

Medicare Commission Dispute Update: CMS’ Repsonse What Agents Need to Know

The growing conflict between insurers and state regulators has caused federal officials to step in to clarify who controls Medicare Advantage (MA) marketing practices. The latest Medicare commission dispute update dives in to CMS’ response to the current status of broker commissions. Several insurers have reduced or eliminated commissions and restricted access to enrollment tools. Therefore, state commissioners are pushing back, arguing these actions harm both agents and beneficiaries. CMS’ latest memo signals that the debate is far from over.

Medicare Advantage Enrollment Suppression

In recent months, multiple insurers have attempted to limit what they view as costly Medicare Advantage enrollment by adjusting broker compensation and curbing access to online enrollment portals. These moves have prompted roughly a dozen states to urge insurers to reverse course. Some state departments even issued cease-and-desist orders, sparking lawsuits from carriers.

On December 4, CMS issued a memo stating; regulation of Medicare Advantage and Part D ultimately rests at the federal level. The agency emphasized that federal law likely preempts state law on matters related to MA compensation and marketing. CMS also reminded stakeholders that commissions are negotiable annually, as long as they fall within federal limits.

Access to Enrollment Forms

Importantly, CMS did clarify one requirement: enrollment forms must remain accessible on insurers’ websites. This comes amid concerns that restricted access to online tools could limit beneficiaries’ ability to make informed choices.

Agents; join the team at Crowe – click here for online contracting

Agent Compensation

While CMS’ memo reaffirmed federal authority, states are unlikely to stay silent. Several state regulators have said they lack the authority to mandate compensation changes but continue urging insurers to restore commissions. Industry observers expect states to keep applying public pressure, even if their legal power is limited. Some also suggest states could focus attention on the Medicare Supplement market, which is regulated at the state level, especially as some carriers consider commission changes in that space as well.

Agents and brokers have voiced growing frustration as certain insurers have reduced or eliminated commissions; sometimes even retroactively. Many argue that these cuts ultimately hurt beneficiaries by reducing access to professional guidance during enrollment.

Watch a YouTube video – Multiple Medicare Advantage Plans going non-commissionable

The dispute has escalated significantly. Insurers have filed lawsuits in response to state actions, claiming that limiting commissions is part of their strategy to maintain plan stability amid rising costs. Meanwhile, regulators in several states have urged insurers to reinstate compensation, warning of the broader impact on consumers.

Let’s Sum it Up

With the 2025 Annual Enrollment Period now over and the 2026 window on the horizon, the tension between state regulators, insurers, and federal authorities is shaping what could become a pivotal policy fight. CMS’ memo clarifies federal preemption but leaves the door open for continued pressure from states. For agents, the message is clear: the debate over Medicare Advantage commissions is far from settled. The outcome will have meaningful implications for how the industry operates moving forward.

Stay up-to-date on agent events and information

What Medicare Part D Covers: A Clear Guide for Medicare Beneficiaries

Medicare Part D is essential for millions of beneficiaries who rely on prescription medications to manage chronic conditions and maintain their health. Understanding what Medicare Part D covers can help you choose the right plan, avoid unexpected costs, and make the most of your Medicare benefits. This guide breaks down the key features of Part D coverage so you know exactly what to expect.

What Is Medicare Part D

Medicare Part D is prescription drug coverage offered by private insurance companies approved by Medicare. Beneficiaries can enroll in a stand-alone Prescription Drug Plan (PDP) with Original Medicare or choose a Medicare Advantage plan (MA-PD) that includes drug benefits. Every plan must follow Medicare’s minimum coverage rules, but formularies and pricing vary.

What Medicare Part D Covers

Prescription Drugs in Essential Categories

All Medicare Part D plans must cover drugs across major therapeutic classes, including medications for:

• Diabetes
• High blood pressure
• High cholesterol
• COPD and asthma
• Depression and anxiety
• Osteoporosis

This ensures beneficiaries have access to commonly used medications for chronic conditions.

Watch a quick YouTube video on the prescription payment plan

Protected Class Medications

Medicare Part D also requires plans to cover “protected class” drugs, which include:

• Antidepressants
• Antipsychotics
• Anticonvulsants
• Antiretrovirals
• Immunosuppressants
• Certain cancer medications

These protections ensure that people with serious or complex health needs can access the full range of necessary treatments.

Vaccines Not Covered by Part B

Part D covers many important vaccines, including the shingles (Shingrix) vaccine, RSV vaccines, and most travel immunizations. Under current Medicare rules, beneficiaries typically pay $0 out of pocket for recommended vaccines.

Insulin and Diabetic Supplies

Thanks to recent updates, Medicare Part D limits monthly insulin costs to $35 for covered insulin products. Many plans also cover diabetic supplies such as test strips, lancets, and pen needles.

Specialty and High-Cost Medications

Part D covers a wide range of specialty drugs used for conditions like multiple sclerosis, rheumatoid arthritis, and autoimmune disorders. These medications may fall into higher cost tiers but are included in most formularies.

Agents; are you ready to join the Crowe team – click here for online contract

What Medicare Part D Does Not Cover

Medicare Part D does not cover over-the-counter drugs, vitamins and supplements, cosmetic medications, fertility treatments, or drugs for weight loss.

Medicare Part D provides comprehensive, affordable access to prescription medications. By reviewing your plan’s formulary, comparing costs, and choosing a plan that matches your medication needs, you can maximize your coverage and save money throughout the year.

Stay up-to-date on agent events and information

Medicare Advantage OEP 2026: What Beneficiaries Need to Know

As in previos years, the Medicare Advantage OEP 2026 runs from January 1 to March 31, giving Medicare beneficiaries a valuable second chance to fine-tune their health coverage. While the Annual Enrollment Period (AEP) in the fall gets the most attention, OEP is just as important; especially with the growing number of changes expected in Medicare Advantage benefits, Star Ratings, utilization management, and supplemental offerings in 2026.

Here’s an overview of what OEP is, how it works, and why 2026 may be an especially important year to review plan choices.

What Is the Medicare Advantage OEP

The Medicare Advantage OEP is a once-per-year enrollment window designed specifically for people already enrolled in a Medicare Advantage plan. It allows beneficiaries to:

• Switch to a different Medicare Advantage plan (with or without drug coverage)
• Drop Medicare Advantage and return to Original Medicare
• Enroll in a stand-alone Part D prescription drug plan if switching back to Original Medicare

However, OEP does not allow someone on Original Medicare to join a Medicare Advantage plan. It is strictly for current MA members who want to make a change.

Why OEP Matters in 2026

Medicare Advantage plans are expected to see continued adjustments in 2026, including:

More Care Management Controls

Many carriers are tightening prior authorization, utilization management, and cost-sharing rules. Some beneficiaries may find their 2026 MA plan more restrictive than expected once the new year begins.

Shifts in Supplemental Benefits

Non-medical extras like dental, vision, hearing, transportation, and OTC allowances are being closely reviewed by CMS. Some plans reduced benefits for 2026 to balance rising medical costs.

Watch a quick video on the differences between Medicare Advantage vs Medicare Supplements

Star Rating Modifications

With CMS proposing changes to the Star Ratings program, some plans entered 2026 with lower ratings than previous years. Lower ratings can mean reduced rebates, resulting in trimmed benefits or higher out-of-pocket costs for members.

Provider Network Adjustments

Every year brings hospital and physician network changes. Beneficiaries often don’t notice these changes until January, making OEP their opportunity to switch to a plan with more compatible providers.

With these shifts, OEP 2026 will be especially important for those who discover their new coverage doesn’t meet their expectations.

Who Should Consider Making a Change

A Medicare Advantage member may want to explore options during OEP if:

• Their plan dropped key doctors or specialists for 2026
• Prescription costs or formularies changed
• Supplemental benefits were reduced or removed
• Prior authorization requirements increased
• Their total out-of-pocket costs are higher than anticipated
• They enrolled in a new plan during AEP but are experiencing “buyer’s remorse”

Even a small change; like a different tier placement for a medication can significantly impact annual healthcare expenses.

How to Review Medicare Advantage Options During OEP

During OEP, beneficiaries should:

1. Review their 2026 Evidence of Coverage (EOC) to understand changes.
2. Compare local plan alternatives, focusing on doctors, drug coverage, and copays.
3. Check Star Ratings, but also evaluate real-world factors like provider access.
4. Consider switching back to Original Medicare if they prefer provider flexibility; though Medigap underwriting rules may apply depending on the state.

Working with a licensed Medicare agent is the quickest way to compare plans side-by-side and avoid unexpected coverage gaps.

Agents; join the team at Crowe – click here for online contracting

The Medicare Advantage Open Enrollment Period is a valuable opportunity for beneficiaries to correct course after the new plan year begins. With ongoing regulatory changes and shifting benefits in 2026, OEP gives Medicare members the flexibility to ensure their plan still aligns with their healthcare needs, budget, and preferred providers.

Whether it’s a minor adjustment or a full switch, the OEP helps ensure beneficiaries start the rest of 2026 with confidence in their coverage.

Stay up-to-date on agent events and information

Proposed Medicare Advantage Changes 2027

The Centers for Medicare & Medicaid Services (CMS) recently released a proposed rule for the 2027 contract year that could reshape Medicare Advantage (MA) and Part D prescription drug coverage. The agency aims to “strengthen quality, improve access, and modernize benefits” while reducing administrative burdens on plans.

Here’s what beneficiaries, providers, and policymakers need to know.

Star Ratings Overhaul

CMS proposes removing 12 Star Rating measures that are largely administrative or show little variation between plans. The focus will shift to meaningful metrics, including clinical outcomes, preventive care, and patient experience.

• New focus on outcomes: Plans will be evaluated more on health results than paperwork.
• Mental health measure: CMS plans to introduce a “Depression Screening and Follow-Up” measure for future cycles.
• Health equity bonuses paused: The previously planned “Excellent Health Outcomes for All” bonus is postponed, though CMS invites feedback on equity initiatives.

Impact: Beneficiaries may find it easier to identify high-quality plans, while insurers may redirect resources toward improving actual care.

Enrollment Flexibility

The proposed rule adds a new Special Enrollment Period (SEP) for beneficiaries whose providers leave a plan’s network. This allows mid-year plan changes without waiting for the regular enrollment window. CMS also codifies other existing SEP policies, making the system more consistent.

Impact: This change ensures continuity of care for people with chronic conditions or preferred providers.

Watch a video on the discontinued Medicare advantage plan special enrollment period

Part D and Drug Coverage Updates

The rule formalizes Part D reforms started under prior legislation, including:

• Eliminating the coverage gap (donut hole) phase.
• Maintaining reduced out-of-pocket thresholds.
• Removing cost-sharing in the catastrophic phase.
• Adjusting how True Out-of-Pocket (TrOOP) costs are calculated.

Impact: Beneficiaries gain more predictable and affordable prescription drug coverage.

Agents, are you ready to join the team at Crowe; click here

Reducing Administrative Burden

CMS proposes measures to reduce paperwork and regulatory complexity, such as:

• Exempting certain account-based plans from creditable coverage disclosures.
• Lifting requirements for mid-year notices about unused supplemental benefits.
• Removing some health-equity reporting mandates for plans.

Impact: Plans may operate more efficiently, but some transparency and oversight could be reduced.

Why It Matters

1. Patient-focused quality: More emphasis on outcomes and experience could improve care.
2. Drug cost protection: Part D reforms continue to protect beneficiaries from high out-of-pocket expenses.
3. Flexible enrollment: The new SEP enhances access to care when providers leave networks.
4. Efficiency vs. oversight: Streamlined administration may improve plan operations but reduce some accountability.
5. Future reform: CMS is constantly making changes to improve MA plans, and stakeholders have the chance to provide input.

CMS’s 2027 proposed rule could bring meaningful improvements for beneficiaries while easing administrative burdens for insurers. The Star Ratings overhaul, enrollment flexibility, and Part D updates are poised to enhance care and reduce costs. However, reduced oversight and postponed equity initiatives highlight areas to watch as the public-comment process unfolds.

Agents, stay up-to-date on the our latest webinars an agent events.

Medicare Supplement Plan Sales Growth

As Medicare Advantage plans undergo major changes for 2026, more seniors are taking a closer look at Medicare Supplement (Medigap) coverage. With tighter MA budgets, reduced benefits, and growing network concerns, Medigap is becoming the go-to choice for beneficiaries who want simplicity, stability, and predictable healthcare costs. This has helped with Medicare Supplement plan sales growth.

Why Medicare Advantage Changes Are Driving the Shift

For 2026, many Medicare Advantage carriers are reducing cost-sharing perks, scaling back extras, and becoming more selective with enrollment growth. Factor in increased marketing scrutiny and commission pressure, and the MA landscape feels less predictable than it has in years.

Seniors are noticing; many are now reevaluating whether MA plans still fit their needs.

Agents; join the team at Crowe – click here for online contracting

Why Medicare Supplement Plans Stand Out in 2026

1. Predictable Costs and Simple Coverage

Medigap helps shield members from unexpected bills by covering the gaps in Original Medicare. Plan G and other popular options remain consistent year after year.

2. Freedom From Networks

Members can see any doctor or hospital nationwide that accepts Medicare; no referrals, no authorizations, and no surprises.

3. Long-Term Stability

While MA benefits change annually, Medigap benefits do not. This makes Medigap especially appealing amid shifting MA offerings.

How to Position Medigap in Your Sales Strategy

• Lead with predictability: Emphasize long-term cost stability compared to fluctuating MA benefits.
• Highlight provider freedom: Seniors frustrated with shrinking MA networks respond well to Medigap’s nationwide access.
• Target MA switchers: Many beneficiaries use the Medicare Advantage Open Enrollment Period to move into more stable coverage.
• Educate early: Start conversations before annual plan changes create confusion or frustration.

Watch a quick YouTube video on MA OEP best practices

Key Takeaways

• Medicare Advantage plans are cutting back on supplemental benefits and tightening networks for 2026.
• Medicare Supplement plans offer predictability, nationwide access, and long-term stability.
• Demand is increasing as seniors seek more control and fewer surprises.
• Agents can leverage this shift to build trust, long-term relationships, and stronger retention.

As Medicare Advantage plans tighten benefits in 2026, Medicare Supplement insurance stands out as a stable, reliable alternative. For agents, this shift presents a strong opportunity to guide clients toward coverage that offers flexibility, control, and predictable healthcare spending.

Stay up-to-date on agent events and information

Why Offer Cigna CHS Plans – A Smart Add-On for Today’s Medicare Market

Why offer Cigna CHS plans; in today’s shifting healthcare landscape, consumers are more concerned than ever about unexpected medical costs. This is especially true of those triggered by major health events like cancer, heart attacks, and strokes. For agents, this concern represents a major opportunity. Cigna’s Cancer, Heart Attack & Stroke (CHS) plans have quickly become one of the most valuable supplemental products to offer alongside Medicare Advantage, Medigap, and individual health insurance.

Here’s why CHS coverage should be part of your 2026 sales strategy.

CHS Plans Fill a Critical Financial Gap

Cancer, heart attacks, and strokes are among the costliest and most common medical events for U.S. adults. Even insured clients often face:

• High deductibles and co-pays
• Hospitalization charges
• Travel and lodging for treatment
• Lost income or caregiver costs

Cigna’s CHS plans provide a lump-sum cash benefit clients can use for anything; medical or non-medical. This flexibility allows families to stay financially stable during the most stressful moments of their lives.

Watch a quick YouTube video on ancillary plan sales

Cigna Offers Strong, Recognizable Branding

Cigna is a trusted national name, and clients feel confident purchasing protection from a carrier they already associate with quality and service. This instantly boosts your credibility and reduces objection rates that often happen with lesser-known supplemental carriers.

Simple, Streamlined Underwriting

Cigna’s underwriting for CHS plans are straightforward, agent-friendly, and designed for quick approvals. This makes CHS an easy add-on during:

• Medicare Advantage reviews
• Medigap comparisons
• ACA Special Enrollment conversations
• Life insurance appointments

Faster underwriting means more closed sales and fewer follow-ups.

Competitive Premiums & High Value for the Client

CHS premiums remain very affordable; even for clients on a fixed income. For many households, adding this coverage costs less per month than common streaming subscriptions. Yet the payout during a claim can be life-changing.

For agents, this creates a high-value, low-resistance product that clients appreciate and rarely cancel.

A Perfect Cross-Sell During Annual Reviews

If you’re an active Medicare agent, you’re already meeting clients every year. CHS coverage fits seamlessly into that conversation:

“Your current plan looks good, but let’s also talk about financial protection if something major happens.”

These products can add revenue, boost client retention, and strengthen your role as a full-service advisor.

Easy to Explain, Easy to Sell

You don’t need complex charts or benefit summaries. Clients understand cancer, heart attacks, and strokes; they’ve seen friends, family, or coworkers experience them. The product is relatable and instantly makes sense.

Agents, are you ready to join the team at Crowe; click here

Helps Protect Your Book of Business

When you offer supplemental solutions that truly help clients, they are far more likely to stay with you long-term. CHS adds stickiness to your business and positions you as a proactive agent who delivers value, not just someone who enrolls clients into a single plan.

Cigna’s Cancer, Heart Attack & Stroke plans are one of the simplest and most impactful products you can add to your portfolio in 2026. They support your clients, improve financial security, and create a reliable revenue stream for your business.

Agents, stay up-to-date on the our latest webinars an agent events.

If you’re looking for a product that offers strong benefits, easy conversations, and meaningful protection; Cigna CHS is a must-have in your lineup.

Medicare Advantage Compensation Loss – State Regulators Push Back

The tension between state insurance regulators and Medicare Advantage (MA) carriers is reaching a new level. As insurers continue tightening their budgets and limiting new enrollment; often by cutting commissions to brokers and restricting access to online applications. Some state officials are challenging what they view as unfair and potentially unlawful practices when it comes to Medicare advantage compensation loss.

With the 2026 Medicare Annual Enrollment Period (AEP) already underway, this conflict could shape the future of how MA plans are marketed, sold, and regulated.

Why Carriers Are Reducing Broker Compensation

Financial pressures have been building within Medicare Advantage for several years. Rising utilization costs, increased regulatory scrutiny, and shrinking federal reimbursement have pushed Medicare insurers to prioritize profit stability over rapid membership growth.

As part of this shift, some carriers have:

• Eliminated or reduced commissions on specific plans
• Limited access to agent-facing online enrollment platforms
• Discouraged new enrollments that could attract higher-cost members

The carriers intend to use these measures to control risk and protect margins. Although for brokers and agents, the fallout is immediate; lost income, lowered client expectations, and fewer ways to serve Medicare beneficiaries effectively.

Watch a YouTube video on SEPs for discontinued Medicare advantage plans

States Begin to Challenge Commission Cuts

Insurance commissioners in Delaware, Idaho, Montana, Oklahoma, New Hampshire, and North Dakota have taken a firm stance: cutting or withholding commissions to reduce Medicare Advantage enrollment crosses the line into unfair trade practices.

Some regulators have directly warned carriers to stop using marketing tactics that restrict enrollment or disadvantage third-party marketers. Others have gone further:

• Idaho issued cease-and-desist orders against UnitedHealthcare and PacificSource for allegedly violating state insurance standards.
• Additional states have threatened penalties, sanctions, or legal action if insurers refuse to restore fair broker compensation.

State officials argue that if MA plans are sold within their borders, insurers must comply with state marketing and sales laws regardless of the program’s federal oversight.

The Stakes Are High for Both Sides

This conflict puts both insurers and brokers; and ultimately beneficiaries, in a difficult position.

For insurers, compliance with state demands could trigger:

• Tighter pricing
• Fewer $0 premium plans
• Potential consideration of market exits

As one industry expert noted, when carriers feel they cannot adjust compensation or enrollment strategy to manage risk, they may be more likely to scale back or leave smaller markets.

However, carriers also have strong incentives not to leave states completely. If an insurer exits a Medicare Advantage market, it is barred from re-entering for years. This could present a long-term setback few companies want to face.

For brokers, reduced compensation means:

• Inconsistent or unpredictable payment
• Competing against carriers that restrict access to enrollment platforms
• Difficulty supporting clients when carriers remove commissions after applications are already submitted

Marketing groups emphasized that commissions are built into plan pricing and actuarial calculations. In other words; carriers planned for these costs long before selling the product.

If you are a Medicare agent and want to join the team at Crowe; click here for online contracting.

Legal and Regulatory Questions

A key unresolved issue is whether state regulators have the authority to intervene in the sales and marketing of a federal healthcare program like Medicare Advantage.

Many legal experts believe states have more power than carriers acknowledge. They regulate:

• Agent licensing
• Marketing conduct
• Fair business practices within state borders

Some policy analysts argue that states may actually hold more leverage than CMS in enforcing sales and marketing standards; especially when unfair business practices affect consumers or licensed agents.

Idaho’s insurance director has signaled that the state expects legal challenges and is prepared to defend its position. This includes efforts to force insurers to retroactively pay withheld commissions.

On the other hand, insurers may counter-sue states, arguing that Medicare’s federal structure preempts state authority.

Where This Leaves Brokers and Beneficiaries

As this dispute unfolds, brokers remain stuck in the middle. They must comply with evolving state rules while navigating restrictive carrier policies. At the same time, beneficiaries risk losing access to the knowledgeable agents they rely on to explain coverage options, especially in rural or underserved markets.

Let’s Sum it all up

• Medicare Advantage carriers are reducing or eliminating broker commissions to limit new enrollment and protect margins.
• Insurance regulators in at least six states are challenging these tactics and threatening enforcement actions.
• If insurers restore full commissions, they risk enrolling higher-cost or unprofitable members, creating financial strain.
• The question of whether states can regulate MA sales and marketing remains unresolved, setting up likely court battles.

Stay updated on agent webinars and events.

Using Medicare Advantage Trial Rights: What Beneficiaries Need to Know

Choosing Medicare coverage is a major decision. For some beneficiaries, enrolling in a Medicare Advantage (MA) plan feels like a smart move comprehensive benefits, low or $0 premiums, and added perks like dental, vision, and fitness programs. But what happens if you try Medicare Advantage and realize it’s not the right fit? That’s where using Medicare Advantage Trial Rights can be a valuable safety net.

Medicare built specific protections that allow certain beneficiaries to “test” a Medicare Advantage plan without being locked in forever. Understanding these rights can give you confidence when making your coverage decision.

What Are Medicare Advantage Trial Rights

Medicare Advantage Trial Rights are special protections that allow eligible beneficiaries to switch back to Original Medicare (Part A and Part B) and purchase a Medigap (Medicare Supplement) plan if they decide MA isn’t working for them. These rights prevent beneficiaries from being denied Medigap coverage or charged more due to health conditions during this trial period.

Who Qualifies for Medicare Advantage Trial Rights

You may qualify if:

1. You are new to Medicare and you first enrolled in a Medicare Advantage plan.
If you joined an MA plan when you first became eligible for Medicare at age 65, you have a 12–month trial period. If you decide within that year that MA is not for you, you can switch back to Original Medicare and have Medigap guaranteed issue rights.

2. You dropped a Medigap plan to enroll in Medicare Advantage for the first time.
If you previously had a Medigap plan and switched to an MA plan for the first time, you again have 12 months to change your mind. If you return to Original Medicare, you have the right to get the same Medigap plan you had before (if it’s still available) or a comparable plan.

Watch a YouTube video – Medicare Advantage vs. Medicare Supplements

Why Trial Rights Matter

Trial rights offer peace of mind. Medicare Advantage plans work well for many people, but provider networks, prior authorization rules, and cost-sharing structures may not suit everyone. Trial rights allow beneficiaries to explore coverage options without long-term risk.

For example, someone who values nationwide access to doctors or has upcoming health procedures might discover that Original Medicare plus Medigap better suits their needs. With trial rights, they can make the switch confidently.

If you an agent who is ready to join Crowe team; click here for online contracting

How to Use Your Trial Rights

If you decide to switch back from Medicare Advantage to Original Medicare:

Contact Medicare or your plan to disenroll
Apply for a Medigap plan, citing your trial right
Choose a standalone Part D prescription drug plan (PDP) if needed

Timing is key; make sure you act within your 12-month window to secure guaranteed Medigap eligibility.

Medicare Advantage can be a great choice, but it’s not one-size-fits-all. Medicare Advantage Trial Rights give beneficiaries a valuable opportunity to try MA coverage with a safety net. If you’re unsure which route is best, speak with a licensed Medicare professional who can help evaluate your health needs, budget, and coverage preferences.

Understanding your rights empowers you to make confident, informed decisions about your Medicare journey.

Agents, stay up-to-date on the our latest webinars an agent events.